Grass pollinosis
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1)Male and female patients over 5 years old and under 65 years old on the day of informed consent (2)Patients with moderate or severe nasal symptoms of nasal discharge, nasal congestion, sneezing, or itching or eye symptoms of foreign body sensation in eyes/hyperemia/itching or lacrimation outside the house (particularly in the places where weeds can be seen, such as riverbeds, fields, rice paddies, open spaces, etc.), and with requirement of medication therapy, during the recent grass pollen season (May to August) (3)Patients who may be able to appropriately enter their condition of pollinosis in the electronic diary by smartphone or tablet device (the parents when patients are aged < 12 years on the day of informed consent)
Exclusion criteria
Exclusion criteria: (1)Patients who received specific immunotherapy for Grass, Cypress, Birch, Alder, Ragweed, Mugwort or Japanese Hop pollinosis for at least 1 month from within 5 years prior to the day of first observation (Visit 1) to the day of second observation (Visit 2) (2)Patients who received laser treatment or surgery for the treatment of nasal symptoms from within 1 years prior to the day of first observation (Visit 1) to the day of second observation (Visit 2) (3)Patients who are unlikely to complete the study or who are expected to change their living environment during the study period (e.g., moving and lifestyle changes such as higher education and employment)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| From May to August, Rhinoconjunctivitis Symptom Score, Rhinoconjunctivitis Madication Score, Total Rhinoconjunctivitis Symptom and Madication Score, Proportion of the subjects used medication for symptom of pollinosis, and the daily each pollen counts from May to August, pollen are Grass, Cypress, Birch, Alder, Ragweed, Mugwort, Japanese Hop. | — |
Contacts
Torii Pharmaceutical Co.,Ltd